179 related articles for article (PubMed ID: 36678825)
1. Eutectic Mixture Formation and Relaxation Dynamics of Coamorphous Mixtures of Two Benzodiazepine Drugs.
Valenti S; Cazorla C; Romanini M; Tamarit JL; Macovez R
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678825
[TBL] [Abstract][Full Text] [Related]
2. Comparative Physical Study of Three Pharmaceutically Active Benzodiazepine Derivatives: Crystalline versus Amorphous State and Crystallization Tendency.
Valenti S; Barrio M; Negrier P; Romanini M; Macovez R; Tamarit JL
Mol Pharm; 2021 Apr; 18(4):1819-1832. PubMed ID: 33689364
[TBL] [Abstract][Full Text] [Related]
3. Design of a Stable Coamorphous System Using Lactose as an Antiplasticizing Agent for Diphenhydramine Hydrochloride with a Low Glass Transition Temperature.
Ueda H; Hirakawa Y; Miyano T; Imono M; Tse JY; Uchiyama H; Tozuka Y; Kadota K
Mol Pharm; 2022 Apr; 19(4):1209-1218. PubMed ID: 35316068
[TBL] [Abstract][Full Text] [Related]
4. Drug-Biopolymer Dispersions: Morphology- and Temperature- Dependent (Anti)Plasticizer Effect of the Drug and Component-Specific Johari-Goldstein Relaxations.
Valenti S; Del Valle LJ; Romanini M; Mitjana M; Puiggalí J; Tamarit JL; Macovez R
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269593
[TBL] [Abstract][Full Text] [Related]
5. Effect of electrostatic interactions on the relaxation dynamics of pharmaceutical eutectics.
Wojnarowska Z; Zotowa J; Knapik-Kowalczuk J; Tajber L; Paluch M
Eur J Pharm Sci; 2019 Jun; 134():93-101. PubMed ID: 30986473
[TBL] [Abstract][Full Text] [Related]
6. Determination of Stable Co-Amorphous Drug-Drug Ratios from the Eutectic Behavior of Crystalline Physical Mixtures.
Kissi EO; Khorami K; Rades T
Pharmaceutics; 2019 Nov; 11(12):. PubMed ID: 31771255
[TBL] [Abstract][Full Text] [Related]
7. Relaxation Dynamics vs Crystallization Kinetics in the Amorphous State: The Case of Stiripentol.
Ruiz GN; Romanini M; Barrio M; Tamarit JL; Pardo LC; Macovez R
Mol Pharm; 2017 Nov; 14(11):3636-3643. PubMed ID: 28915351
[TBL] [Abstract][Full Text] [Related]
8. Glass transition in binary eutectic systems: best glass-forming composition.
Wang LM; Li Z; Chen Z; Zhao Y; Liu R; Tian Y
J Phys Chem B; 2010 Sep; 114(37):12080-4. PubMed ID: 20731399
[TBL] [Abstract][Full Text] [Related]
9. Glass transition, crystallization kinetics, and inter-conformer relaxation dynamics of amorphous mitotane and related compounds.
Romanini M; Pérez Valmaseda A; Macovez R
Int J Pharm; 2022 Dec; 629():122390. PubMed ID: 36379398
[TBL] [Abstract][Full Text] [Related]
10. Changes in dynamics of the glass-forming pharmaceutical nifedipine in binary mixtures with octaacetylmaltose.
Kaminska E; Tarnacka M; Kaminski K; Ngai KL; Paluch M
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):185-91. PubMed ID: 26428937
[TBL] [Abstract][Full Text] [Related]
11. Prediction of the Synergistic Glass Transition Temperature of Coamorphous Molecular Glasses Using Activity Coefficient Models.
Zhao X; Cheng S; Koh YP; Kelly BD; McKenna GB; Simon SL
Mol Pharm; 2021 Sep; 18(9):3439-3451. PubMed ID: 34313449
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Stability of New Co-Amorphous Drug Binary Systems: Study of Glass Transitions as a Function of Composition and Shelf Time.
Martínez LM; Videa M; Sosa NG; Ramírez JH; Castro S
Molecules; 2016 Dec; 21(12):. PubMed ID: 27983640
[TBL] [Abstract][Full Text] [Related]
13. Molecular mobility of amorphous S-flurbiprofen: a dielectric relaxation spectroscopy approach.
Rodrigues AC; Viciosa MT; Danède F; Affouard F; Correia NT
Mol Pharm; 2014 Jan; 11(1):112-30. PubMed ID: 24215236
[TBL] [Abstract][Full Text] [Related]
14. Crystallization kinetics and molecular dynamics of binary coamorphous systems of nimesulide and profen analogs.
Zhang J; Shi Q; Qu T; Zhou D; Cai T
Int J Pharm; 2021 Dec; 610():121235. PubMed ID: 34743960
[TBL] [Abstract][Full Text] [Related]
15. Theoretical Model for the Structural Relaxation Time in Coamorphous Drugs.
Phan AD; Knapik-Kowalczuk J; Paluch M; Hoang TX; Wakabayashi K
Mol Pharm; 2019 Jul; 16(7):2992-2998. PubMed ID: 31095393
[TBL] [Abstract][Full Text] [Related]
16. Amorphous solid dispersions of curcumin in a poly(ester amide): Antiplasticizing effect on the glass transition and macromolecular relaxation dynamics, and controlled release.
Valenti S; Arioli M; Jamett A; Tamarit JL; Puiggalí J; Macovez R
Int J Pharm; 2023 Sep; 644():123333. PubMed ID: 37597594
[TBL] [Abstract][Full Text] [Related]
17. Molecular Dynamics and Physical Stability of Coamorphous Ezetimib and Indapamide Mixtures.
Knapik J; Wojnarowska Z; Grzybowska K; Jurkiewicz K; Tajber L; Paluch M
Mol Pharm; 2015 Oct; 12(10):3610-9. PubMed ID: 26301858
[TBL] [Abstract][Full Text] [Related]
18. The Slow Relaxation Dynamics in the Amorphous Pharmaceutical Drugs Cimetidine, Nizatidine, and Famotidine.
Viciosa MT; Moura Ramos JJ; Diogo HP
J Pharm Sci; 2016 Dec; 105(12):3573-3584. PubMed ID: 27773524
[TBL] [Abstract][Full Text] [Related]
19. Molecular Dynamics and Physical Stability of Pharmaceutical Co-amorphous Systems: Correlation Between Structural Relaxation Times Measured by Kohlrausch-Williams-Watts With the Width of the Glass Transition Temperature (ΔT
Chieng N; Teo X; Cheah MH; Choo ML; Chung J; Hew TK; Keng PS
J Pharm Sci; 2019 Dec; 108(12):3848-3858. PubMed ID: 31542436
[TBL] [Abstract][Full Text] [Related]
20. Coamorphous Systems of Valsartan: Thermal Analysis Contribution to Evaluate Intermolecular Interactions Effects on the Structural Relaxation.
Ekawa B; Diogo HP; Castro RAE; Caires FJ; Eusébio MES
Molecules; 2023 Aug; 28(17):. PubMed ID: 37687071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
